Scientific Plenary Sessions

These premier sessions will focus on clinical and basic science issues of interest to all neurologists. There are six Plenary Sessions that feature outstanding lecturers who are leaders in their fields.

• Presidential Plenary Session
• Hot Topics Plenary Session
• Contemporary Clinical Issues and Case Studies Plenary Session
• Frontiers in Clinical Neuroscience Plenary Session
• AAN Awards Plenary Session
• Scientific Program Highlights Plenary Sessions

Tuesday, April 13

Presidential Plenary Session

9:00 a.m.–12:00 p.m.

Moderator: Stefan M. Pulst, MD, FAAN
Chair, Science Committee and Scientific Program Subcommittee

Features the AAN's premier lecture awards for clinically relevant research and a presentation by a leading lecturer. Top researchers speak on some of the most significant findings in neurology in 2010. The session concludes with the annual AAN Business Meeting.

Lectures include:

Presidential Lecture:
Stem and Progenitor Cell-Based Treatment of Neurological Disease
Steven A. Goldman, MD, PhD
University of Rochester School of Medicine, Rochester, NY

Robert Wartenberg Lecture:
Midlife Risk Profile and Later Life Cognitive Decline and Dementia
Philip A. Wolf, MD, FAAN
Boston University School of Medicine, Boston, MA

Sidney Carter Award in Child Neurology:
Endowed by an anonymous donor.

Pediatric Stroke: Recent Insights From an Emerging Field
Gabrielle A. DeVeber, MD
Hospital for Sick Children Division of Neurology, Toronto, ON, Canada

George C. Cotzias Lecture:
Endowed by Roche Pharmaceuticals, Inc.

Deciphering the Molecular Mechanisms of Alzheimer's Disease Predicts Novel Therapies
Dennis J. Selkoe, MD, FAAN
Brigham and Women's Hospital, Boston, MA

AAN/AAN Professional Association Business Meeting

You are encouraged to stay for the annual AAN/AAN Professional Association Business Meeting immediately following the final lecture to find out the latest in Academy business and information.

Back to top.

Hot Topics Plenary Session

5:30 p.m.–6:30 p.m.
MTCC, Exhibit Hall FG

Moderator: Raymond P. Roos, MD, FAAN
Member, Science Committee

This session highlights important and interesting abstracts presented at subspecialty meetings leading up to the Annual Meeting that are not on the program but should be heard by a wide audience at the Annual Meeting. Topics are selected by the AAN Science Committee and AAN Scientific Program Subcommittee.

Title: "Whole Exome Sequencing: The future is now"
Jeffrey M. Vance, MD, PhD
University of Miami, Miami, FL

Topic: CREST Trial
Thomas G. Brott, MD, FAAN
Mayo Clinic–Jacksonville, Jacksonville, FL

Title: "Devices for Epilepsy"
Gregory A. Worrell, MD
Mayo Clinic–Rochester, Rochester, MN

Title: "Comparative Effectiveness Research"
S. Claiborne Johnston, MD, PhD
University of San Francisco, San Francisco, CA

Back to top.

Wednesday, April 14

Contemporary Clinical Issues and Case Studies Plenary Session

9:00 a.m.–12:00 p.m.
MTCC, Exhibit Hall FG

Moderator: Carlayne E. Jackson, MD, FAAN
Member, Science Committee

This session highlights issues most critical to practicing neurologists, including abstracts related to new therapeutic developments, clinical applications of basic and translational research, and innovative technical developments. In addition to the Contemporary Clinical Issues discussion, a case study format addresses topics of interest.

David B. Clifford, MD, FAAN
Washington University School of Medicine/Saint Louis, MO
Discussant: Kenneth L. Tyler, MD, FAAN/Denver, CO

David W. Dodick, MD
Mayo Clinic–Phoenix/Phoenix, AZ
Discussant: Anne Louise Oaklander, MD, PhD, FAAN/Lincoln, MA

Hans-Christoph Diener, MD, PhD, FAHA, FAAN
University Duisburg-Essen/Essen Germany<
Discussant: Robert G. Hart, MD/San Antonio, TX

In addition to the Contemporary Clinical Issues discussion, a case study format will be presented by the following presenters:

Title: "Sports Concussion"
Jeffrey S. Kutcher, MD
University of Michigan Hospital/Ann Arbor, MI

Title: "Spinal Muscular Atrophy: A Story of Rags to Riches"
John T. Kissel, MD, FAAN
Ohio State University/Columbus, OH

Topic: CDC and H1N1
James J. Sejvar, MD
Centers for Disease Control and Prevention/Decatur, GA

Back to top.

Thursday, April 15

Frontiers in Clinical Neuroscience Plenary Session

9:00 a.m.–11:00 a.m.

Moderator: Stefan M. Pulst, MD, FAAN
Chair, Science Committee and Scientific Program Subcommittee

Focuses on translational research related to clinical issues of importance. Four physician scientists outline their recent research findings, along with the clinical implications.

• "Reflections on Memory: What Neurosurgical Patients Have Taught Us"
  Brenda Milner, PhD
  Montreal Neurological Institute, Montreal, QC, Canada
• "Clinical Spectrum and cellular Mechanisms of Autoimmunity to NMDA and Other Synaptic Receptors"
  Josep O. Dalmau, MD, PhD
  University of Pennsylvania, Philadelphia, PA
• "Stroke and Alzheimer's Disease: Fellow Travelers or Partners in Crime?"
  Vladimir Hachinski, MD, DSc, FAAN
  London Health Center, London, ON, Canada
• "Neurologists Listening to Neurons: Intracortically Based Brain-Computer Interfaces"
  Leigh R. Hochberg, MD, PhD
  Massachusetts General Hospital and Brigham and Women's Hospital; Harvard Medical School; Brown University; Providence VA Medical Center, Boston, MA

Back to top.

AAN Awards Plenary Session 4:00 p.m.–6:00 p.m. Moderator: Brenda Banwell, MD Member, Science Committee The Awards Plenary Session highlights some of the best and brightest in the field today, featuring presentations by the recipients of four top 2010 awards. Sure to become a staple of future Annual Meetings, three of the lectures will become perennials: The Potamkin Prize for Research in Pick's, Alzheimer's, and Related Diseases, the Sheila Essey Award—An Award for ALS Research, and the John Dystel Prize for Multiple Sclerosis Research, with the fourth lecture in rotation. In 2010 the rotating lecture will feature a presentation from the recipient of the Dreifuss-Penry Epilepsy Award.

Sheila Essey Award—An Award for ALS Research Presented by the American Academy of Neurology and the ALS Association and supported through the philanthropy of the Essey Family Fund and the ALS Association. Recipient: Clive Svendsen, PhD/ Los Angeles, CA
Dreifuss-Penry Epilepsy Award Sponsored by the American Academy of Neurology and endowed by members of the AAN Epilepsy Section; Abbott Laboratories, Inc.; Cephalon, Inc.; Cyberonics, Inc.; Elan Pharmaceuticals, Inc.; GlaxoSmithKline; Novartis Pharmaceuticals; Ortho-McNeil Neurologics; Pfizer Inc; Shire US, Inc; and UCB Pharma. Recipient: Martin Gallagher, MD, PhD/ Nashville, TN
Potamkin Prize for Research in Pick's, Alzheimer's, and Related Diseases Sponsored by the American Academy of Neurology, the AAN Foundation, and funded through the philanthropy of the Potamkin Family. Recipients: Bruce L. Miller, MD/ San Francisco, CA; Recipients: Lennart Mucke, MD/ San Francisco, CA
John Dystel Prize for Multiple Sclerosis Research Presented by the American Academy of Neurology and the National Multiple Sclerosis Society and made possible through a special contribution from the John Dystel Multiple Sclerosis Research Fund at the National Multiple Sclerosis Society. Recipient: David Hafler, MD, MSc/ New Haven, CT

Friday, April 16 Scientific Program Highlights Plenary Session 5:15 p.m.–6:15 p.m. MTCC, Theatre 102 Moderator: Stefan M. Pulst, MD, FAAN Chair, Science Committee and Scientific Program Subcommittee

Reviews the most critical new research from more than 2,000 studies presented throughout the 2010 Scientific Program. Education programs will end at 5:00 p.m. Friday, allowing time for meeting participants to attend this session.

For more information, please contact Tina Novack at tnovack@aan.com or (651) 695-2734.

Back to top.